"DRC Ebola News (10/24/19)." CSIS Commission on Strengthening America's Health Security, Center for Strategic and International Studies, October 24, 2019. Accessed June 12, 2020.

Daily update for October 24th, 2019 on the Ebola outbreak in eastern Democratic Republic of the Congo (DRC)

Photo Credit: Mike Stone/Getty Images

There were 6 new cases reported on October 23rd.

Rate of new infections in the DRC continue to drop, as a vaccine moves closer to approval.

Communique on cross-border coordination, partnerships, and communication for Ebola virus disease preparedness in at-risk member states

DRC MoH Statistics/WHO AFRO Dashboard (as of October 23)

WHO AFRO Dashboard

Total cases: 3,256

  • Confirmed cases: 3,139
  • Probable cases: 117
  • Suspected cases: 536

Deaths: 2,171

Vaccinated: 241,601

The Ebola outbreak is finally slowing down


By Amy Maxmen, 10/22/19

At the outbreak’s peak in April, roughly 300 new infections were reported in three weeks. Between 25 September and 15 October, fifty people were diagnosed with Ebola in the DRC. The drop in infections is not a reason to relax efforts to contain the virus, WHO director-general Tedros Adhanom Ghebreyesus told reporters on 18 October. “We must treat every case as if it is the first since every case has the potential to spark a new outbreak,” he said. Ebola responders have pushed the virus out of Beni, but the virus continues to spread in remote parts of North Kivu and Ituri provinces, where violence has complicated response efforts.

More positive news came on 18 October after the European Medicines Agency (EMA) recommended that the European Commission (EC) approve the Merck Ebola vaccine which is currently being used in DRC. The EC will decide within 10 weeks on whether to approve the vaccine for sale. The US FDA fast-tracked the vaccine’s application for approval in September, and a decision is expected in March 2020. Seven other experimental Ebola vaccines are at earlier development stages.


Tweet by UN Multi-Partner Trust Fund Office– 10/23/19


The Ebola pooled fund was designed with a clear focus on results, building on the comparative advantages of the UN and with a very agile financing structure. A summary of advantages below

Tweet by TASS– 10/23/19


‘The best in the world’: Putin lauds effectiveness of Russia’s revolutionary Ebola vaccine

Next Article